XML 83 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Dec. 15, 2022
May 02, 2022
Jan. 04, 2021
May 08, 2017
Mar. 29, 2021
Dec. 16, 2020
May 16, 2019
Jul. 18, 2018
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Feb. 19, 2020
Shareholders' Equity (Details) [Line Items]                          
Trading, description                 For each Ordinary Share purchased under the SEDA, YA will pay 93% of the lowest daily VWAP (as defined below) of the Ordinary Shares during the three consecutive trading days, following the date of an advance notice from the Company (provided such VWAP was greater than or equal to 90% of the last closing price of the Ordinary shares at the time of delivery of the advance notice). Notwithstanding the forgoing, the notice shall not exceed $500.        
Ordinary shares issued                     45,000    
Prepaid expenses (in Dollars)                   $ 140      
Ordinary shares issued         7,188           41,090 158,023  
Ordinary shares issued (in Dollars)                       $ 465  
Commitment fee (in Dollars)                     $ 77    
Gross proceeds (in Dollars)     $ 2,000       $ 1,000            
Ordinary shares, shares authorized 8,000,000   800,000     6,000,000 400,000 4,000,000 11,000,000 8,000,000      
Shares issued, Price per share (in Dollars per share)             $ 2.5            
Issuance expenses (in Dollars)     $ 1,841       $ 65            
Warrants issued             240,000            
Warrants exercise price (in Dollars per share)             $ 3.3            
Warrant, description                 The warrants were exercisable for 3.5 years and were subject to a three-year vesting period as follows: one third of the warrants shall vest annually (upon the lapse of 12 months, 24 months and 36 months from issuance), provided that on the applicable vesting date the investor did not sell any of the Ordinary Shares purchased in the private placement. Vesting of all of the warrants was to be accelerated in the event that any one or more shareholders acting together acquire a block of 40% of the Company’s issued and outstanding share capital. In addition, the Company issued 60,000 warrants as fees to a placement agent.        
Purchase warrants     720,000                    
Purchase price per shares (in Dollars per share)     $ 2.5                    
Exercise price per share (in Dollars per share)     $ 2.75                    
Debt instrument, description                 The loan was paid in 12 monthly installments of principal and interest starting from March 2020. BOS issued to YA II warrants to purchase up to 100,000 Ordinary Shares of the Company at an exercise price of $3.00 per Ordinary Share. The Company allocated on amount of $30 with respect to such warrants under “additional paid in capital” and as a discount on the loan. The discount was reflected as financing expenses over the term of the loan. As of December 31, 2021 the entire balance of the loan was repaid. The warrants were exercisable for a period of two years from issuance and on February 19, 2022, expired without being exercised.        
Ordinary Shares of no nominal value 3,000,000         2,000,000   2,000,000          
Authorized shares 11,000,000         8,000,000   6,000,000          
Ordinary shares nominal value           8,000,000              
Ordinary shares   450,000                      
Purchase price per shares (in Dollars per share)   $ 2.2                      
Exercise price per shares (in Dollars per share)   $ 2.2                      
Total amount (in Dollars)   $ 990                      
Net issuance expenses (in Dollars)   $ 911                      
Share based compensation options description                 Each option granted under the Plan expires five years from the date of the grant.        
Capital gain tax rate                 25.00%        
Exercisable annual period                 3 years        
Ordinary shares bonus (in Dollars)         $ 27                
Vesting period                 3 years        
Share-based compensation expense (in Dollars)                 $ 97 $ 67 65    
Intrinsic value of options (in Dollars)                 $ 0 $ 70 $ 12    
Minimum [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Issuance of ordinary shares 300,000                        
Maximum [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Issuance of ordinary shares 1,000,000                        
Stock Option [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Share based compensation options description                 In May 2003, the Company’s shareholders approved the adoption of the 2003 Israeli Stock Option Plan or the Plan. In December 2012, the Company’s shareholders approved a 10 year extension to the Plan, according to which the Board of Directors may grant options under the Plan through May 31, 2023. In December 2017, the shareholders approved an increase of the pool of shares reserved for issuances under the Plan, to 500,000 Ordinary Shares. In July 18, 2018, the Company’s shareholders approved (i) an increase of the number of Ordinary Shares available for issuance under the Plan, by 200,000 to a total of 700,000 Ordinary Shares, and (ii) an amendment of the Plan allowing for the grant of Ordinary Shares in addition to options.         
Options available for future grants                 285,284        
Weighted-average grant-date fair value of options granted (in Dollars per share)                 $ 0.82 $ 1.2 $ 0.76    
Weighted-average grant-date fair value of unvested options (in Dollars per share)                 $ 1.02        
Options exercised                 1,000 52,167 84,618    
Non-vested share-based compensation (in Dollars)                 $ 191 $ 219      
YA [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Issuance of ordinary shares (in Dollars)       $ 2,000                  
Commitment fee (in Dollars)                       $ 35  
Gross proceeds (in Dollars)                     $ 100    
YA [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Ordinary shares issued (in Dollars)                     $ 23    
Ordinary Shares [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Ordinary shares issued                 67,307        
Directors and Officers [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Ordinary shares issued                   175,000      
Directors and Officers [Member] | YA [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Ordinary shares issued                 87,500        
Directors and Officers [Member] | Ordinary Shares [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Ordinary shares issued                 87,500        
CEO, Eyal Cohen [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Ordinary shares issued 80,000                        
Ziv Dekel [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Ordinary shares issued 7,500                        
Ruby Tech Inc [Member] | YA [Member]                          
Shareholders' Equity (Details) [Line Items]                          
Principal amount (in Dollars)                         $ 600,000
Interest rate                         8.00%